论文部分内容阅读
Background and Objective: Little is known about the incidence of hepatitis B virus (HBV) infection in Hodgkin’s lymphoma patients. This study was to evaluate the impact of HBV infection on the survival of Hodgkin’s lymphoma patient. Methods: Clinical data of 120 Hodgkin’s lymphoma patients treated at the Sun Yat-sen University Cancer Center between January 2004 and October 2007 were collected. The impact of prognostic factors including HBV infection on survival was examined by univariate and multivariate analyses. A log-rank test was used for univariate analysis and the Cox proportional hazards regression model was used for multivariate analysis. Results: Of the 120 patients, 18 (15.0%) were hepatitis B virus surface antigen (HBsAg)-positive. The HBsAg-positive patients had lower 5-year survival rate than did the HBsAg-negative ones (66.9% vs. 91.3%, P = 0.006). When the patients were divided into early-stage (Ⅰ+Ⅱ) and advanced-stage (Ⅲ+Ⅳ) groups, the 5-year survival rate was significantly different between the HBsAg-positive and -negative patients in early-stage group (64.8% vs. 96.0%, P < 0.001), while not significantly different in advanced-stage group (75.0% vs. 84.8%, P=0.667). Both univariate and multivariate analyses showed that radiotherapy and HBV infection were independent prognosis factors for the patients with early-stage Hodgkin’s lymphoma (P=0.006 and 0.014, respectively). Conclusions: The incidence of HBV infection is similar between Hodgkin’s lymphoma patients and normal population. HBV infection is an independent prognosis factor for survival in the patients with early-stage Hodgkin’s lymphoma.
Background and Objective: Little is known about the incidence of hepatitis B virus (HBV) infection in Hodgkin’s lymphoma patients. This study was to evaluate the impact of HBV infection on the survival of Hodgkin’s lymphoma patients. Methods: Clinical data of 120 Hodgkin’s lymphoma patients treated at the Sun Yat-sen University Cancer Center between January 2004 and October 2007 were collected. The impact of prognostic factors including HBV infection on survival was examined by univariate and multivariate analyzes. A log-rank test was used for univariate analysis and the Cox proportional hazards regression model was used for multivariate analysis. Results: Of the 120 patients, 18 (15.0%) were hepatitis B virus surface antigen (HBsAg) -positive. The HBsAg-positive patients had lower 5-year survival rate than did the HBsAg -negative ones (66.9% vs. 91.3%, P = 0.006). When the patients were divided into early-stage (Ⅰ + Ⅱ) and advanced-stage ignificantly different between the HBsAg-positive and -negative patients in the early-stage group (64.8% vs. 96.0%, P <0.001) while not significantly different in the advanced-stage group (75.0% vs. 84.8%, P = 0.667) Both univariate and multivariate analyzes showed that radiotherapy and HBV infection were independent prognosis factors for the patients with early-stage Hodgkin’s lymphoma (P = 0.006 and 0.014, respectively). Conclusions: The incidence of HBV infection is similar between Hodgkin’s lymphoma patients and normal population. HBV infection is an independent prognosis factor for survival in the patients with early-stage Hodgkin’s lymphoma.